11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6774/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :06/08/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : "PIPERAZINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY"<br />

(51) International classification :C07D 213/56 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :60/763,051 1)BRISTOL-MYERS SQUIBB COMPANY,<br />

(32) Priority Date :27/01/2006<br />

Address <strong>of</strong> Applicant :ROUTE 206 AND PROVINCE LINE<br />

(33) Name <strong>of</strong> priority country :U.S.A.<br />

ROAD, PRINCETON, NEW JERSEY 08543-4000, USA. U.S.A.<br />

(86) International Application No<br />

:PCT/US07/061014 (72)Name <strong>of</strong> Inventor :<br />

Filing Date<br />

:25/01/2007 1)PERCY H. CARTER,<br />

(87) International Publication No :WO 2007/087585 2)CULLEN L. CAVALLARO<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

3)GEORGE V. DE LUCCA<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The present application describes modulators <strong>of</strong> MIP-lα <strong>of</strong> formula (I): or stereoisomers or pharmaceutically acceptable salts there<strong>of</strong>,<br />

wherein m, T, W, R1, R4,, R5, R5a <strong>and</strong> R5b are as defined herein. In addition, methods <strong>of</strong> treating <strong>and</strong> preventing inflammatory<br />

diseases such as asthma <strong>and</strong> allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis <strong>and</strong> atherosclerosis<br />

using said modulators are disclosed.<br />

No. <strong>of</strong> Pages : 185 No. <strong>of</strong> Claims : 23<br />

The Patent Office Journal 24/10/2008 26184

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!